Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.5B | 8.1B | 7.6B | 7.5B |
Cost of revenue | 5.9B | 6.2B | 5.5B | 5.5B |
Gross profit | 1.6B | 2.0B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 996.1M | 1.1B | 925.3M |
Operating income | 270.7M | 711M | 572.8M | 889.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 119.9M | 206M | 105.3M | 119.2M |
Other income expense | — | — | — | — |
Pretax income | 299.1M | 613.8M | 527.5M | 910.5M |
Tax provision | 105.1M | 228.6M | 175.8M | 285M |
Net income | 194M | 385M | 351.7M | 625.5M |
Basic EPS | — | 1.9 | 1.7 | 3.1 |
Diluted EPS | — | 1.9 | 1.7 | 3.1 |
Basic average shares | — | 203.7M | 203.3M | 203.7M |
Diluted average shares | — | 203.7M | 203.3M | 203.7M |
EBITDA | 511.3M | 914.7M | 727.8M | 1.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |